[Combined therapy with insulin and alpha-glucosidase inhibitor].
Watanabe
K
K
Department of Medicine, Metabolism & Endocrinology, Juntendo University School of Medicine.
Kawamori
R
R
D020909:Acarbose; D056486:Chemical and Drug Induced Liver Injury; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004304:Dosage Forms; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects; D014312:Trisaccharides / Q000008:administration & dosage* / Q000009:adverse effects
D004304:Dosage Forms; D004791:Enzyme Inhibitors; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D007328:Insulin; D014312:Trisaccharides; D020909:Acarbose